Squadron Capital Management LLC
Q3 2026 13F filing
Updated 6 days ago45 disclosed positions worth $398.5M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | K KODIAK SCIENCES INC | $39.8M | 420.0K | 9.99% | — |
| 2 | B C4 THERAPEUTICS INC | $31M | 9.32M | 7.79% | — |
| 3 | C COGENT BIOSCIENCES INC | $29.3M | 915.0K | 7.35% | — |
| 4 | K KODIAK SCIENCES INC | $25.6M | 270.0K | 6.42% | — |
| 5 | S SILENCE THERAPEUTICS PLC | $22.8M | 2.08M | 5.72% | — |
| 6 | ? N/A ZENTALIS PHARMACEUTICALS INC | $18.9M | 6.83M | 4.75% | — |
| 7 | E EDGEWISE THERAPEUTICS INC | $17.3M | 425.0K | 4.33% | — |
| 8 | R RELAY THERAPEUTICS INC | $14.2M | 785.0K | 3.56% | — |
| 9 | O ORIC PHARMACEUTICALS INC | $13.5M | 1.00M | 3.38% | — |
| 10 | R RELMADA THERAPEUTICS INC | $13.2M | 3.50M | 3.31% | — |
| 11 | D DEFINIUM THERAPEUTICS INC | $12.9M | 340.0K | 3.25% | — |
| 12 | P PHARVARIS N V | $12.7M | 400.0K | 3.18% | — |
| 13 | A ADLAI NORTYE GROUP LTD | $12.2M | 764.9K | 3.07% | — |
| 14 | V VERA THERAPEUTICS INC | $9.8M | 305.0K | 2.47% | — |
| 15 | I INVENTIVA SA | $8.9M | 2.40M | 2.22% | — |
| 16 | I DISC MEDICINE INC | $8.8M | 134.5K | 2.21% | — |
| 17 | C COGENT BIOSCIENCES INC | $8.5M | 265.0K | 2.13% | — |
| 18 | A AVALO THERAPEUTICS INC | $6.9M | 450.0K | 1.73% | — |
| 19 | A ACLARIS THERAPEUTICS INC | $6.3M | 1.20M | 1.58% | — |
| 20 | R REZOLUTE INC | $5.5M | 1.32M | 1.38% | — |
| 21 | A ASSEMBLY BIOSCIENCES INC | $5.3M | 225.0K | 1.33% | — |
| 22 | A ADAGENE INC | $5.2M | 1.62M | 1.30% | — |
| 23 | C CRESCENT BIOPHARMA INC. | $5.1M | 350.0K | 1.28% | — |
| 24 | Y YARROW BIOSCIENCE INC | $5.1M | 225.0K | 1.27% | — |
| 25 | Z ZURA BIO LTD | $5M | 1.20M | 1.25% | — |
| 26 | ? N/A TCGX ACQUISITION CORP | $4.6M | 370.2K | 1.16% | — |
| 27 | C CONTINEUM THERAPEUTICS INC | $4.3M | 323.6K | 1.09% | — |
| 28 | A ARRIVENT BIOPHARMA INC | $4.3M | 142.5K | 1.08% | — |
| 29 | I INHIBIKASE THERAPEUTICS INC | $4.1M | 2.00M | 1.03% | — |
| 30 | ? N/A PALISADE BIO INC | $4M | 3.00M | 1.02% | — |
| 31 | T TANGO THERAPEUTICS INC | $3.7M | 150.0K | 0.94% | — |
| 32 | J JANUX THERAPEUTICS INC | $3.7M | 215.0K | 0.93% | — |
| 33 | S SAVARA INC | $3.5M | 675.0K | 0.87% | — |
| 34 | C CONTINEUM THERAPEUTICS INC | $3M | 225.0K | 0.76% | — |
| 35 | I QUINCE THERAPEUTICS INC | $2.8M | 90.0K | 0.70% | — |
| 36 | J JATT III ACQUISITION CORP | $2.8M | 250.0K | 0.69% | — |
| 37 | S SCYNEXIS INC | $2.5M | 515.0K | 0.64% | — |
| 38 | S SILENCE THERAPEUTICS PLC | $2M | 180.0K | 0.49% | — |
| 39 | A ALX ONCOLOGY HLDGS INC | $1.9M | 1.40M | 0.49% | — |
| 40 | L LIPOCINE INC NEW | $1.8M | 810.0K | 0.45% | — |
| 41 | B BIOAGE LABS INC | $1.8M | 250.0K | 0.44% | — |
| 42 | P PEPGEN INC | $1.5M | 600.0K | 0.36% | — |
| 43 | B C4 THERAPEUTICS INC | $1.3M | 400.0K | 0.33% | — |
| 44 | J JATT II ACQUISITION CORP | $731K | 65.0K | 0.18% | — |
| 45 | ? N/A ZENTALIS PHARMACEUTICALS INC | $277K | 100.0K | 0.07% | — |